248 related articles for article (PubMed ID: 12829665)
1. High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas.
Haas RL; Poortmans P; de Jong D; Aleman BM; Dewit LG; Verheij M; Hart AA; van Oers MH; van der Hulst M; Baars JW; Bartelink H
J Clin Oncol; 2003 Jul; 21(13):2474-80. PubMed ID: 12829665
[TBL] [Abstract][Full Text] [Related]
2. Effective palliation by low dose local radiotherapy for recurrent and/or chemotherapy refractory non-follicular lymphoma patients.
Haas RL; Poortmans P; de Jong D; Verheij M; van der Hulst M; de Boer JP; Bartelink H
Eur J Cancer; 2005 Aug; 41(12):1724-30. PubMed ID: 16039113
[TBL] [Abstract][Full Text] [Related]
3. Breast lymphoma. A B-cell spectrum including the low grade B-cell lymphoma of mucosa associated lymphoid tissue.
Mattia AR; Ferry JA; Harris NL
Am J Surg Pathol; 1993 Jun; 17(6):574-87. PubMed ID: 8333556
[TBL] [Abstract][Full Text] [Related]
4. Extranodal nonorbital indolent lymphomas of the head and neck: relationship between tumor control and radiotherapy.
MacDermed D; Thurber L; George TI; Hoppe RT; Le QT
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):788-95. PubMed ID: 15183482
[TBL] [Abstract][Full Text] [Related]
5. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
6. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
Neelis KJ; Schimmel EC; Vermeer MH; Senff NJ; Willemze R; Noordijk EM
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):154-8. PubMed ID: 18834672
[TBL] [Abstract][Full Text] [Related]
7. Low-dose radiotherapy in indolent lymphoma.
Rossier C; Schick U; Miralbell R; Mirimanoff RO; Weber DC; Ozsahin M
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e1-6. PubMed ID: 21398049
[TBL] [Abstract][Full Text] [Related]
8. Outcome of hyperfractionated radiotherapy in chemotherapy-resistant non-Hodgkin's lymphoma.
Martens C; Hodgson DC; Wells WA; Sun A; Bezjak A; Pintilie M; Crump M; Gospodarowicz MK; Tsang R
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1183-7. PubMed ID: 16376490
[TBL] [Abstract][Full Text] [Related]
9. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome.
Tsang RW; Gospodarowicz MK; Pintilie M; Wells W; Hodgson DC; Sun A; Crump M; Patterson BJ
J Clin Oncol; 2003 Nov; 21(22):4157-64. PubMed ID: 14615444
[TBL] [Abstract][Full Text] [Related]
10. High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: an effective regimen with low morbidity and mortality.
Wadhwa PD; Fu P; Koc ON; Cooper BW; Fox RM; Creger RJ; Bajor DL; Bedi T; Laughlin MJ; Payne J; Gerson SL; Lazarus HM
Biol Blood Marrow Transplant; 2005 Jan; 11(1):13-22. PubMed ID: 15625540
[TBL] [Abstract][Full Text] [Related]
11. Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior.
Suh CO; Shim SJ; Lee SW; Yang WI; Lee SY; Hahn JS
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):228-33. PubMed ID: 16503386
[TBL] [Abstract][Full Text] [Related]
12. Time to treatment response in patients with follicular lymphoma treated with bortezomib is longer compared with other histologic subtypes.
O'Connor OA; Portlock C; Moskowitz C; Hamlin P; Straus D; Gerecitano J; Gonen M; Dumitrescu O; Sarasohn D; Butos J; Neylon E; Mac-Gregor Cortelli B; Blumel S; Evens AM; Zelenetz AD; Wright J; Cooper B; Winter J; Vose J
Clin Cancer Res; 2010 Jan; 16(2):719-26. PubMed ID: 20068103
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy for low-grade gastric marginal zone lymphoma: a retrospective study.
Lin ML; Wirth A; Chao M; Milner AD; DiIulio J; MacManus M; Seymour JF
Intern Med J; 2007 Mar; 37(3):172-80. PubMed ID: 17316336
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of concomitant chemoradiotherapy in bulky refractory or chemoresistant relapsed lymphomas.
Girinsky T; Lapusan S; Ribrag V; Koscielny S; Ferme C; Carde P
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):476-9. PubMed ID: 15667970
[TBL] [Abstract][Full Text] [Related]
15. Highly effective local control and palliation of mantle cell lymphoma with involved-field radiation therapy (IFRT).
Rosenbluth BD; Yahalom J
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1185-91. PubMed ID: 16682133
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy for stage I-III nodal low-grade non-Hodgkin's lymphoma.
Ott OJ; Rödel C; Gramatzki M; Niedobitek G; Sauer R; Grabenbauer GG
Strahlenther Onkol; 2003 Oct; 179(10):694-701. PubMed ID: 14566478
[TBL] [Abstract][Full Text] [Related]
17. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
[TBL] [Abstract][Full Text] [Related]
18. Low-grade non-hodgkin lymphomas.
Tsang RW; Gospodarowicz MK
Semin Radiat Oncol; 2007 Jul; 17(3):198-205. PubMed ID: 17591567
[TBL] [Abstract][Full Text] [Related]
19. Palliation by low-dose local radiation therapy for indolent non-Hodgkin lymphoma.
Chan EK; Fung S; Gospodarowicz M; Hodgson D; Wells W; Sun A; Pintile M; Tsang RW
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e781-6. PubMed ID: 21167657
[TBL] [Abstract][Full Text] [Related]
20. Treatment results of tonsillar lymphoma: a 10-year experience.
Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]